¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sodium channel blocking agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • antifoaming agent
    Ç×±âÆ÷Á¦, ±âÆ÷Á¦°ÅÁ¦
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antiinflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
  • antiviral agent
    Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×¹ÙÀÌ·¯½º¹°Áú
  • agent
    1. ¹°Áú 2. ÀÎÀÚ 3. -¾à, -Á¦
  • alkylating agent
    ¾Ëųȭ¾à¹°, ¾ËųȭÁ¦
  • anesthetic agent
    ¸¶ÃëÁ¦
  • biologic agent
    »ý¹°ÇÐÀûÁ¦Á¦
  • bacteriostatic agent
    Á¤±ÕÁ¦
  • bulking agent
    ÀåÈ®À强¾à¹°
  • compounding agent
    ¹èÇÕÁ¦, Á¶ÇÕÁ¦
  • contrast agent
    Á¶¿µÁ¦
  • carcinogenic agent
    ¹ß¾Ï¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antiallergic agent
    ¾Ë·¹¸£±â¾à
  • antiarrhythmic agent
    Ç׺ÎÁ¤¸ÆÁ¦
  • antiasthmatic agent
    (¢¡antasthmatic) Ç×õ½ÄÁ¦
  • antifoaming agent
    Ç×±âÆ÷Á¦, ±âÆ÷Á¦°ÅÁ¦
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
  • antiviral agent
    Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×¹ÙÀÌ·¯½º¹°Áú
  • bacteriostatic agent
    Á¤±ÕÁ¦
  • biologic agent
    »ý¹°ÇÐÀûÁ¦Á¦
  • bulking agent
    ÀåÈ®À强¾à¹°
  • carcinogenic agent
    ¹ß¾Ï¹°Áú
  • carcinostatic agent
    Á¦¾ÏÁ¦
  • cardioactive agent
    ½ÉÀåÀÛ¿ë¾à
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶ÃëÁ¦.
  • anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥).
  • anorexiant =anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥), ½Ä¿å¾ïÁ¦Á¦.
  • anorexigenic agent
    ½Ä¿å¾ïÁ¦Á¦.
  • anti-inflammatory agent
    Ç׿°Áõ¾à(ù÷æúñøå·).
  • antiallergic agent
    Ç׾˷¹¸£±â¾à.
  • antiallergic agent =a. drug
    Ç׾˷¹¸£±â¾à.
  • antianticholinesterase agent
    Ç×-Ç×Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦.
  • antiarrhythmic agent
    Ç׺ÎÁ¤¸ÆÁ¦<¾à>.
  • antiarrhythmic agent =a. drug
    Ç׺ÎÁ¤¸ÆÁ¦<¾à>.
  • antiasthmatic agent =antasthmatic
    Ç×õ½Ä¾à(ù÷ô·ãÓå·).
  • antibacterial agent
    Ç×»ýÁ¦
  • antibacterial agent
    Ç×±Õ¾à(ù÷жå·), Ç×±Õ¹°Áú(ù÷жڪòõ), Ç×±ÕÁ¦(ù÷жð¥).
  • antibacterial agent
    Ç×±Õ¾à(ù÷жå·), Ç×±Õ¹°Áú, Ç×±ÕÁ¦.
  • anticariogenic agent
    1. Ç׿ì½Ä¼º ¾à<¹°Áú>(ù÷ó»ãÚàõå·<Úªòõ>). 2. Ç׿ì½Ä¼ºÀÎÀÚ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • thought blocking
    »ç°íÂ÷´Ü(ÞÖÍÅó´Ó¨).
  • vagal blocking
    ¹ÌÁֽŰæÂ÷´Ü(¡­ó´Ó¨).
  • acetylcholine channel
    ¾Æ¼¼Æ¿Äݸ° Åë·Î
  • calcium channel
    Ä®½·Åë·Î( -÷×ÖØ).
  • calcium channel
    Ä®½· Åë·Î(÷×ÖØ)
  • calcium channel antagonist,blocker
    Ä®½·Åë·Î ±æÇ×Á¦( -÷×ÖØ ÑÏù÷ð¥),Â÷´ÜÁ¦(ó´Ó¨ð¥).
  • cation channel
    ¾ç(åÕ)À̿ Åë·Î(÷×ÖØ)
  • channel
    Åë·Î.
  • channel
    Åë·Î(÷×ÖØ)
  • channel block
    Åë·ÎÂ÷´Ü
  • channel former
    Åë·ÎÇü¼º¹°Áú.
  • chloride channel
    ¿°¼ÒÀÌ¿ÂÅë·Î
  • collateral channel
    °çÅë·Î, ºÎÇà·Î(Üùú¼ÖØ).
  • collector channel
    Áý°á°ü, Áý°á·Î
  • hepatocardiac channel
    °£½ÉÀå__ÊÜãýíôϵ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • emulsifying agent
    ¿¡¸ÖÁ¯È­Á¦(ûùð¥)
  • F agent
    F Á¦(ð¥)
  • fusogenic agent
    À¶ÇÕ »ý¼ºÁ¦(ë×ùêßæà÷ð¥)
  • germicidal agent
    »ì±ÕÁ¦(߯жð¥)
  • immunosuppressive agent
    ¸é¿ª¾ï¾ÐÁ¦(Øóæ¹åääâð¥)
  • lipotropic agent
    ÁöÁúµ¿¿øÁ¦(ò·òõÔÑê¬ð¥)
  • lympholytic agent
    ¸²ÇÁ±¸¿ëÇØÁ¦(éÁú°ð­)
  • lysosomotropic agent
    ¶óÀ̼ÒÁ»ÀÚ±ØÁ¦(í©Ð»ð¥)
  • methylating agent
    ¸ÞƿȭÁ¦(ð¥)
  • mutagenic agent
    º¯ÀÌ¿øÁ¦(ܨì¶ê«ð¥)
  • oxidizing agent
    »êÈ­Á¦(ß«ûùð¥)
  • precipitating agent
    ħ°­Á¦(öØË½ð¥)
  • pressor agent
    Ç÷¾Ð»ó½ÂÁ¦(úìäâß¾ã°ð¥)
  • reducing agent
    ȯ¿ø ½Ã¾à(ü½êªãËå·)
  • sequestering agent
    °ÝÀýÇü¼ºÁ¦(̰ï¾û¡à÷ð¥)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PSL parasternal line; photostimulable luminescence; potassium, sodium chloride, and sodium lactate [solu...
SB Bachelor of Science; Schwartz-Bartter [syndrome]; serum bilirubin; shortness of breath; sick bay; si...
SPS scapuloperoneal syndrome; shoulder pain and stiffness; simple partial seizures; slow-progressive sch...
STS sequence tagged site; serologic test for syphilis; sodium tetradecyl sulfate; sodium thiosulfate; st...
ROC Receptor Operated Channel
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CAA Chicken anaemia agent
FWA fluorescent whitening agent
SMA Snow Mountain Agent
UCA ultrasound contrast agent
AA alkylating agent
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hexobarbital sodium
    Çí»ç¹Ù¸£ºñÅ» ³ªÆ®·ý
  • meralluride sodium
    ¸Þ¶ö·ç¶óÀÌµå ³ªÆ®·ý
  • morrhuate sodium : °£À¯ÀÇ Áö¹æ»ê ³ªÆ®·ý¿°. °æÈ­Á¦·Î¼­ ƯÈ÷ Á¤¸Æ·ù ¹× Ä¡ÁúÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç Á¤¸Æ·ù ³»·Î ¿ë¾×À» ÁÖ»çÇÑ´Ù.

    morrhuic acid

    ¸ð·çÀλê
  • naproxen sodium

    naprylate (³ªÇÁ¸±·¹ÀÌÆ®

    ÇǺΠÁø±ÕÁõÀÇ Ä¡·áÁ¦.
  • serum sodium
    Ç÷û ³ªÆ®·ý
  • sodium
    ³ªÆ®·ý
    ¹é»öÀÇ ¾ËÄ®¸®¼º ±Ý¼Ó ¿ø¼Ò, Na, ¿øÀÚ ¹øÈ£ 11, ¿øÀÚ·® 22.990, ºñÁß 0.971, ¿øÀÚ°¡ 1.
  • sodium alginate
    ¾ËÁø»ê ³ªÆ®·ý
    ¾à ¾ËÄ®¸®¸¦ »ç¿ëÇÏ¿© °¥»ö ÇØÃʷκÎÅÍ ÃßÃâ Á¤Á¦µÈ ź¼öÈ­¹° ÇöŹ¾× ¿ëÁ¦·Î ¾²ÀδÙ. ¶ÇÇÑ À¯È­ ÀÛ¿ë, ¾ÈÁ¤È­ ÀÛ¿ë, ³óÈ­ ÀÛ¿ë, ¼ö°áÇÕ ÀÛ¿ëÀ» °¡ÁüÀ¸·Î½á À½½Ä¹°, ÀǾàǰ, È­Àåǰ µî¿¡ »ç¿ëµÈ´Ù.
  • sodium benzoate
    ¾È½ÄÇâ»ê ³ªÆ®·ý
    ¾È½ÄÇâ»êÀÇ ³ªÆ®·ý¿°. ¹é»öÀÇ °ú¸³»ó ¶Ç´Â °áÁ¤¼º ºÐ¸». Ç×Áø±Õ¼º ¾àǰ. °£ ±â´É °Ë»ç¿ëÀ¸·Î »ç¿ëµÈ´Ù.
  • sodium biphosphate
    ÀÌÀÎ»ê ³ªÆ®·ý
    ÀλêÀÇ monohydrate ÀÏ ³ªÆ®·ý¿°. ¹«»öÀÇ °áÁ¤ ¶Ç´Â ¹é»öÀÇ °áÁ¤¼º ºÐ¸». Ç×Ä®½· °úÀ× Ç÷Á¦, ¼³»ç ¾àÀ¸·Î¼­ ÀÎ»ê ³ªÆ®·ý°ú ÇÔ²² Åõ¿©µÈ´Ù. ¿äÀÇ »ê¼ºÈ­Á¦·Îµµ ¾²ÀδÙ.
  • sodium bisulfite
    Áß¾ÆÈ²»ê ³ªÆ®·ý
    ¾ÆÈ²»ê ¼ö¼Ò ³ªÆ®·ý. ¿©·¯ °¡ÁöÀÇ Á¦¾à¿¡ Ç×»êÈ­Á¦·Î »ç¿ëµÈ´Ù.
  • sodium carbonate
    ź»ê ³ªÆ®·ý
    ¹«»öÀÇ °áÁ¤ ¶Ç´Â ¹é»öÀÇ °áÁ¤¼º ºÐ¸». Á¦¾×¿¡¼­ ¾ËÄ®¸®È­ ¾àǰÀ¸·Î »ç¿ëÇÑ´Ù. ¶ÇÇÑ Àμ³À» ÀÏÀ¸Å°´Â ÇǺκ´ÀÇ Ä¡·á¿¡ »ç¿ëÇϸç, ¼¼Á¤Á¦·Îµµ ¾²ÀδÙ.
  • sodium citrate
    ±¸¿¬»ê ³ªÆ®·ý
    C6H5Na3O7. ±¸¿¬»êÀÇ »ï³ªÆ®·ý¿°.
  • sodium exchange resin
    ³ªÆ®·ý ±³È¯ ¼öÁö, ¼Òµð¿ò ±³È¯ ¼öÁö
  • sodium fluoride denitifrice
    ºÒÈ­ ³ªÆ®·ý Ä¡¾à
  • sodium glutamate
    ±Û·çŸ¹Î»ê ³ªÆ®·ý
    ¾Æ¹Ì³ë»êÀÇ ÇϳªÀÎ L-±Û·çŸ¹Î»êÀÇ ³ªÆ®·ý¿°. ÁÁÀº ¸ÀÀ» Áö³à Á¶¹Ì·á·Î¼­ Àß ¾Ë·ÁÁ® ÀÖ´Ù. D-ü´Â Ưº°ÇÑ ¸ÀÀ» Áö´Ï°í ÀÖÁö ¾Ê´Ù. l-±Û·çŸ¹Î»êÀº ³ú ´ë»ç¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç ¾Ï¸ð´Ï¾Æ¿Í °áÇÕÇØ ±Û·çŸ¹ÎÀÌ µÇ¹Ç·Î ÀúÇ÷´ç È¥¼ö, °£¼º È¥¼ö ½Ã³ª ¾Ï¸ð´Ï¾Æ ÇØµ¶¿¡ »ç¿ëÇÑ´Ù. ´Ù·® »ç¿ë ½Ã¿¡´Â ¾ËÄ®·Î½Ã½º, ¿À½É, ±¸Åä, µÎºÎ ¾Ð¹Ú°¨, µÎÅë µîÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖ´Ù. À̰ÍÀº Á¶¹Ì·á¸¦ ´Ù·® »ç¿ëÇÏ´Â ÁßÈ­ ¿ä¸®¸¦ ¸ÔÀº µÚ¿¡ ÀϾ´Â Á¡¿¡¼­ ÁßÈ­ ¿ä¸®Á¡ ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
channel protein <chemistry, physiology> A protein that facilitates the diffusion of molecules/ions across lipid membranes by forming a hydrophilic pore. most frequently multimeric with the pore formed by subunit interactions.
(18 Nov 1997)
channel transport <radiobiology> In inertial fusion research using light ion drivers, describes the use of current-carrying plasma channels (which are magnetically confined to the channel) to transport electron or ion beams between the ion diode and the fusion target. This allows the ion source to stand back from the target.
(09 Oct 1997)
chloride channel Ion channels selective for chloride ions. Various types including ligand activated Cl channels at synapses (the GABA and glycine activated channels), as well as voltage gated Cl channels found in a variety of plant and animal cells.
See: CFTR, MDR.
(18 Nov 1997)
ryanodine receptor calcium release channel Protein complexes that mediate the release of calcium from the sarcoplasmic reticulum in both skeletal and cardiac muscle cells by forming tetrametric complexes. These complexes each then act as a calcium channel. There are three isoforms of the ryr: ryr1, ryr2, and ryr3. Ryr1 is specifically expressed in skeletal muscles and ryr2 in cardiac muscles. Ryr3 is yet another isoform found in non-muscle cells such as neuronal cells.
(12 Dec 1998)
potassium channel Ion channel selective for potassium ions. There are diverse types with different functions, for example: delayed rectifier channels, M channels, A channels, inward rectifier channels, Ca dependent K channels.
(18 Nov 1997)
single channel recording Variant of patch clamp technique.
(18 Nov 1997)
delayed rectifier channel <physiology> The potassium selective ion channels of axons, so called because they change the potassium conductance with a delay after a voltage step.
The name is used to denote any axon like K channel. Various roles for example regulation of pacemaker potentials, generation of bursts of action potentials or generation of long plateaus on action potentials.
(18 Nov 1997)
double-channel catheter A catheter with two lumens, allowing irrigation and aspiration.
Synonym: two-way catheter.
(05 Mar 2000)
ion channel <cell biology> A transmembrane pore that presents a hydrophilic channel for ions to cross a lipid bilayer down their electrochemical gradients.
Some degree of ion specificity is usually observed and typically a million ions per second may flow. Channels may be permanently open, like the potassium leak channel or they may be voltage gated, like the sodium channel or ligand gated like the acetylcholine receptor.
(27 Oct 1998)
ion channel gating The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability.
(12 Dec 1998)
transnexus channel A hexagonal 15-20A
ligand-gated channel A class of ion channel's whose ionic permeability is regulated by cell membrane receptors that respond to specific extracellular chemical signals.
(05 Mar 2000)
ligand gated ion channel A transmembrane ion channel whose permeability is increased by the binding of a specific ligand, typically a neurotransmitter at a chemical synapse. The permeability change is often drastic, such channels let through effectively no ions when shut, but allow passage at up to 10exp7 ions sexp 1 when a ligand is bound. Recently, the receptors for both acetylcholine and GABA have been found to share considerable sequence homology, implying that there may be a family of structurally related ligand gated ion channels.
(18 Nov 1997)
agent <pharmacology> Any power, principle or substance capable of producing an effect, whether physical, chemical or biological.
Origin: L. Agens = acting
(18 Nov 1997)
agent, antihypertensive As the name suggests, a drug aimed at reducing high blood pressure (hypertension).
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • commission agent
    °Å°£²Û;Á߸ÅÀÎ;»ç¼³ ¸¶±ÇÀå¼ö
  • consular agent
    ¿µ»ç ´ë¸®
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • county agent
    (¿¬¹æ.ÁÖÁ¤ºÎ°¡ ÆÄ°ßÇÑ)³ó»ç °í¹®
  • double agent
    ÀÌÁß °£Ã¸
  • estate agent
    ºÎµ¿»ê°ü¸®ÀÎ;Áß°³¾÷ÀÚ
  • fiscal agent
    À繫 ´ë¸® ±â°ü;À繫 ´ë¸®ÀÎ
  • forwarding agent
    ¿î¼Û¾÷ÀÚ
  • free agent
    ÀÚÁÖÀûÀÎ ÇàÀ§ÀÚ;ÀÚÀ¯°è¾à ¼±¼ö )
  • general agent
    ÃѴ븮ÀÎ
  • house agent
    º¹´ö¹æ;°¡¿Á ¸Å¸Å ¼Ò°³¾÷ÀÚ
  • inquiry agent
    (¿µ)»ç½Ç ŽÁ¤
  • insurance agent
    º¸Çè´ë¸®Á¡
  • land agent
    ÅäÁö ¸Å¸Å Áß°³¾÷ÀÚ;ÅäÁö °ü¸®ÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á